GEN Exclusives

More »

GEN News Highlights

More »
May 15, 2007

Dowpharma Licenses Pfenex Expression Technology to Biovel Life Sciences

  • Dowpharma  licensed its Pfenex Expression Technology™ to India-based Biovel Life Sciences. The agreement grants Biovel rights to employ the Pseudomonas fluorescense-based technology for the production of human growth hormone (HGH), a biosimilar product. 

    Dowpharma says it has already developed a high-yield production strain and process for the production of HGH and will prepare and transfer to Biovel a research cell bank and the production process. The agreement provides for an upfront technology access fee, maintenance and milestone fees, as well as royalties on product sales.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Tackling Climate Change

Do you think most companies will respond positively to the People’s Climate March?